Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Susceptibility, Genetic|Chemotherapy Effect
Interventions: DRUG: DT group|DRUG: ET group|DRUG: NX group
Sponsor: Tianjin Medical University Cancer Institute and Hospital